Last reviewed · How we verify
Injection Mecobalamin,
At a glance
| Generic name | Injection Mecobalamin, |
|---|---|
| Also known as | Vitamin B12 |
| Sponsor | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment (PHASE4)
- Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo (NA)
- Clinical Trial of Ultra-high Dose Methylcobalamin for ALS (PHASE3)
- Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy (NA)
- Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury (PHASE4)
- Combination Therapy of Different Antidepressants With Dietary Supplements (NA)
- A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS) (PHASE2, PHASE3)
- A Study in Patients With Amyotrophic Lateral Sclerosis (ALS) (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: